Voxalatamab
Product Specifications
CAS Number
2411871-58-2
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
Voxalatamab (JNJ-63898081), an IgG4 bispecific antibody targeting PSMA and CD3, demonstrates anti-cancer efficacy in prostate cancer research [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
